150 related articles for article (PubMed ID: 22488703)
21. Survivorship: adult cancer survivors.
Ganz PA
Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
[TBL] [Abstract][Full Text] [Related]
22. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
23. Bone health in breast cancer survivors.
Abdel-Razeq H; Awidi A
J Cancer Res Ther; 2011; 7(3):256-63. PubMed ID: 22044804
[TBL] [Abstract][Full Text] [Related]
24. Adverse bone effects during pharmacological breast cancer therapy.
Bjarnason NH; Hitz M; Jorgensen NR; Vestergaard P
Acta Oncol; 2008; 47(4):747-54. PubMed ID: 18465344
[TBL] [Abstract][Full Text] [Related]
25. Cancer treatment-induced bone loss.
Adler RA
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):442-5. PubMed ID: 17982349
[TBL] [Abstract][Full Text] [Related]
26. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.
Hayes SC; Johansson K; Stout NL; Prosnitz R; Armer JM; Gabram S; Schmitz KH
Cancer; 2012 Apr; 118(8 Suppl):2237-49. PubMed ID: 22488698
[TBL] [Abstract][Full Text] [Related]
27. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
[TBL] [Abstract][Full Text] [Related]
28. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology, etiology, and diagnosis of osteoporosis.
Lane NE
Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873
[TBL] [Abstract][Full Text] [Related]
30. Cancer treatment-induced bone loss in breast and prostate cancer.
Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
J Clin Oncol; 2008 Nov; 26(33):5465-76. PubMed ID: 18955443
[TBL] [Abstract][Full Text] [Related]
31. A prospective model of care for breast cancer rehabilitation: function.
Campbell KL; Pusic AL; Zucker DS; McNeely ML; Binkley JM; Cheville AL; Harwood KJ
Cancer; 2012 Apr; 118(8 Suppl):2300-11. PubMed ID: 22488704
[TBL] [Abstract][Full Text] [Related]
32. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
33. [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Guideline for prevention and treatment of osteoporosis update].
Orimo H
Clin Calcium; 2011 Dec; 21(12):123-43. PubMed ID: 22133832
[TBL] [Abstract][Full Text] [Related]
34. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
35. The effects of psychoeducation and telephone counseling on the adjustment of women with early-stage breast cancer.
Sherman DW; Haber J; Hoskins CN; Budin WC; Maislin G; Shukla S; Cartwright-Alcarese F; McSherry CB; Feurbach R; Kowalski MO; Rosedale M; Roth A
Appl Nurs Res; 2012 Feb; 25(1):3-16. PubMed ID: 20974079
[TBL] [Abstract][Full Text] [Related]
36. Cancer-related fatigue: implications for breast cancer survivors.
Berger AM; Gerber LH; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2261-9. PubMed ID: 22488700
[TBL] [Abstract][Full Text] [Related]
37. Reducing the risk of cancer treatment-associated bone loss in patients with breast cancer.
Hadji P; Bundred N
Semin Oncol; 2007 Dec; 34(6 Suppl 4):S4-10. PubMed ID: 18068489
[TBL] [Abstract][Full Text] [Related]
38. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.
Bruder JM; Ma JZ; Basler JW; Welch MD
Urology; 2006 Jan; 67(1):152-5. PubMed ID: 16413352
[TBL] [Abstract][Full Text] [Related]
40. The impact of rehabilitation support services on health-related quality of life for women with breast cancer.
Gordon LG; Battistutta D; Scuffham P; Tweeddale M; Newman B
Breast Cancer Res Treat; 2005 Oct; 93(3):217-26. PubMed ID: 16136270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
